Bindinglaw

US · guidance

CMS SOM App. H, Tag V358

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR

activein force · 2026-07-22 – presentas-observed

494.50(b)(1)

13.4 Clinical results (monitoring patient results; Kt/V)

Monitoring of relevant patient results is recommended to ensure that all parameters

relating to hemodialyzer clearance are being met. Specifically, examination of urea

reduction ratio (URR) or Kt/V over time is necessary. The failure of these results to meet

the expectations of the dialysis prescription should be investigated. Deterioration of a

patient’s clinical condition or variability of routine dialysis procedures (heparinization,

ultrafiltration, dose of erythropoietin stimulating agent) [requires] an investigation of all

practices, including reuse. Reports of investigations should be filed in the complaint log.

Page 161 of 420

Interpretive Guidance § 494.50(b)(1)

AAMI Rationale for the Development and Provisions of this Recommended Practice

A.13.4 Clinical results

Critical assessment of chemistries and the delivered dose of dialysis (Kt/V or urea reduction

ratio), as is done monthly, provides a clear trend line to assess treatment. This scrutiny of the

patient’s treatment and course is the primary confirmation that hemodialyzer performance

anticipated from TCV or other indirect estimation is accurate and adequate. The overall

effectiveness of the entire treatment, not only the clearance of the dialyzers, is measured. No

other measure of the effectiveness of new or reused dialyzers is as clear or relevant. Trend lines

developed from this data characterize the quality of therapy. . . If the practitioner has concerns

for “middle molecules” or other clinical parameters, these factors should also be part of the

assessment of the delivered therapy.

There are many reasons for an apparent reduction in the mass transfer of urea, other than

decreased hemodialyzer clearance as a result of inadequate reprocessing (such as recirculation,

decreased dialysis time or blood flow rate, or an inappropriate dialysis prescription). To

document adequate mass transfer, parallel measurements of pre- and post-creatinine levels are

helpful. When problems develop with any patient or group of patients, monitoring intensity

should be increased, and other methods should be used to analyze the problem and define

corrective action.

History

Rev.

Provenance

Source
cms.gov
Retrieved
2026-07-22
Edition
som-2026-07-22
Content hash
04cb7cde62cb6512ebd34b8a21f2913cd6b931446e3064f4c9c3d3c59d9016f5
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.